Jacobs Levy Equity Management Inc. Takes Position in Ardent Health Partners, LLC (NYSE:ARDT)

Jacobs Levy Equity Management Inc. bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 21,784 shares of the company's stock, valued at approximately $372,000.

A number of other large investors have also made changes to their positions in ARDT. US Bancorp DE purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at approximately $31,000. Bank of New York Mellon Corp raised its position in Ardent Health Partners by 8.2% in the fourth quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock valued at $438,000 after purchasing an additional 1,941 shares during the period. Geode Capital Management LLC lifted its stake in shares of Ardent Health Partners by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 142,563 shares of the company's stock valued at $2,435,000 after purchasing an additional 2,127 shares during the last quarter. R Squared Ltd purchased a new position in shares of Ardent Health Partners during the 4th quarter worth $37,000. Finally, Deutsche Bank AG increased its position in shares of Ardent Health Partners by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after purchasing an additional 2,654 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have commented on ARDT shares. Mizuho decreased their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Guggenheim upped their price objective on shares of Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Morgan Stanley lowered their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Stephens reiterated an "overweight" rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Tuesday. Finally, Royal Bank of Canada restated an "outperform" rating and set a $21.00 price target on shares of Ardent Health Partners in a research note on Thursday, May 15th. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners has an average rating of "Buy" and an average target price of $20.67.

Ardent Health Partners Stock Down 0.3%

Shares of NYSE:ARDT traded down $0.05 during trading on Tuesday, hitting $15.10. The company's stock had a trading volume of 114,845 shares, compared to its average volume of 395,705. Ardent Health Partners, LLC has a fifty-two week low of $11.31 and a fifty-two week high of $20.72. The business has a 50 day moving average price of $13.20 and a two-hundred day moving average price of $14.80. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company has a market capitalization of $2.16 billion and a PE ratio of 9.26.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. As a group, research analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.